Results 171 to 180 of about 148,561 (252)

Stent thrombosis associated with non-response to clopidogrel despite co-administration of aspirin and ibrutinib. [PDF]

Eur Heart J Case Rep
Dirir O, Parker WAE, Haley HA, Gunn JP, Storey RF.   +4 more
europepmc   +1 more source

Cangrelor Bridge for Repeat Cesarean After Third Trimester Percutaneous Coronary Intervention for Total Occlusion NSTEMI

Clinical Case Reports, Volume 14, Issue 6, June 2026.
Visual Summary, case timeline of non‐ST‐elevation MI with PCI followed by cangrelor bridge for classical cesarean delivery. ABSTRACT Acute coronary syndrome is an uncommon but potentially life‐threatening complication in pregnancy, and dual antiplatelet therapy presents challenges in patients requiring cesarean delivery.
Vidya N. Mullangi, Sara Folk, Sneha Sharma, Gillian Belnavis, Shea Macielak, Danielle Blais, Talal Attar, Blair Suter, William H. Marshall V   +8 more
wiley   +1 more source

High-throughput signal detection of hepatotoxic drug-drug interactions in hospitalized elderly patients: an NLP-driven pharmacovigilance study. [PDF]

Ann Med
Ma J, Chen H, Guo C, He G, Yang G.
europepmc   +1 more source

Endovascular Management of a Giant Supraclinoid Internal Carotid Artery Dissecting Pseudoaneurysm Using Flow Diversion and Coiling: A Case Report and Review of Literature

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT We present a case of a giant left supraclinoid ICA dissecting pseudoaneurysm managed successfully with flow diversion and adjunctive coiling, highlighting radiological findings and clinical outcome. Endovascular intervention provides a minimally invasive and durable solution with good clinical and radiological outcomes.
M. Kodeeswaran, S. P. Goutham, M. Naveenkumar, K. P. Priyadarshan, Moyniul Haq, Anand Warrier, Rimpy Jospeh, Shakir Husain Hakim, Bipin Chaurasia   +8 more
wiley   +1 more source

Compliance with the Veterans Health Administration's Pharmacy Benefit Management guidance for duration of clopidogrel following peripheral vascular interventions: a retrospective cohort study. [PDF]

J Manag Care Spec Pharm
Kim SE, McCoy J, Boudreaux-Kelly M, Hutchins F, Cunningham F, Rogal S, Tzeng E, Hall DE, Thorpe CT, Reitz KM.   +9 more
europepmc   +1 more source

Moderate Intensity Statins Plus Ezetimibe Combination Therapy Versus High Intensity Statins Monotherapy After Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis

Clinical Cardiology, Volume 49, Issue 6, June 2026.
ABSTRACT Background High‐intensity statins are standard therapy after percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS), yet tolerability concerns and residual cardiovascular risk remain important challenges. Moderate‐intensity statin therapy combined with ezetimibe has emerged as a potential alternative, although its ...
Emad Uddin Sajid, Muhammad Hasnain Azeem, Alishba Fatima, Syeda Masooma Jafri, Danish Hassan, Taha Ibrahim, Kashish Zehra Manjee, Syed Rayyan Ahmed, Tooba Ali, Rida Shakeel, Muhammad Usman, Raghabendra Kumar Mahato, Danish Bawa   +12 more
wiley   +1 more source

Long-term single antiplatelet therapy for patients with acute coronary syndrome at high-risk for ischemia and bleeding: a precision cohort study. [PDF]

Front Cardiovasc Med
Wanda M, Mengjie L, Jingyao W, Xue S, Xiao W, Cairong L, Yachao L, Zhigang Z, Zengming X.   +8 more
europepmc   +1 more source

A Comparative Analysis of Short‐Term Outcomes of Off Pump Coronary Artery Bypass Grafting Alone or Simultaneous Cerebral Revascularization: A Single‐Center Retrospective Study

Clinical Cardiology, Volume 49, Issue 6, June 2026.
The final flowchart categorizes subjects into two groups: the control group (n = 60) undergoing OPCABG alone and the combined cardiocerebrovascular revascularization group (n = 57). ABSTRACT Objectives The impact of simultaneous coronary artery bypass grafting (CABG) with cerebral revascularization versus CABG alone on perioperative complications and ...
Bo Li, Qing‐Rui Fang, Bo‐Chen Yao, Qing‐Liang Chen, Jun‐Shan Li, Qiang Wang, Feng Zhao, Dong Wei, Dong‐Yan Yang, Jing Sun, Zhi‐gang Guo   +10 more
wiley   +1 more source

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition and Cancer Risk: Insights from a Large Propensity‐Matched Cohort Study

Clinical Pharmacology &Therapeutics, Volume 119, Issue 6, Page 1547-1554, June 2026.
Proprotein convertase subtilisin/kexin type 9 (PCSK9) monoclonal antibodies (mAbs) lower LDL cholesterol and may influence cancer through immunomodulatory pathways. However, their effect on human cancer incidence remains unknown. We conducted a retrospective, propensity score‐matched study (Clalit Health Services, Israel, 2010–2023) comparing PCSK9 ...
Inbar Nardi Agmon, Chen Gurevitz, Tzippy Shochat, Shiri Kushnir, Guy Witberg, Amos Levi, Dan Gilon, Ran Kornowski, Paaladinesh Thavendiranathan, Husam Abdel Qadir, Zaza Iakobishvili   +10 more
wiley   +1 more source

Clopidogrel and vascular disease prevention

In this editorial we consider some aspects of the use of clopidogrel in current clinical practice. Clopidogrel has replaced ticlopidine as an alternative to aspirin. Among the problems with the use of antiplatelet agents is aspirin intolerance.
Mikhailidis DP, Daskalopoulou SS, Stansby G   +2 more
core